CENPF and breast carcinoma: CENPF has been found to be overexpressed in various malignant tumours, such as prostate cancer, breast cancer, and nasopharyngeal carcinoma, and to activate signalling pathways related to malignant tumour progression to promote the proliferation and metastasis of cancer cells11–13.